News
Featured News
Featured News
Featured News
All News
Filter By Year
TriLink CleanCap® mRNA capping technology now accessible to ESJ customers for non-commercial use FUJISAWA (SEPTEMBER 26, 2023) – TriLink BioTechnologies (TriLink®), a Maravai™ LifeSciences company (NASDAQ: MRVI) and global provider of life science reagents and services, has entered into a non-exclusive License and Supply Agreement for TriLink’s CleanCap® mRNA capping technology with Elixirgen Scientific Japan, Inc […]
TOKYO, May 17, 2022 – Ricoh Company, Ltd. and Elixirgen Scientific, Inc. (Baltimore, Maryland, USA) announce that they have agreed and signed a contract for Ricoh to acquire a majority stake in Elixirgen Scientific. Ricoh had previously acquired 34.5% of Elixirgen Scientific’s stock in 2019. By having Elixirgen Scientific as its subsidiary, Ricoh aims to […]
We are excited to announce that Swift Scientific will now be Elixirgen Scientific’s sales representative in the Northeastern US territory. Together we anticipate business expansion with wider support in the region to better serve our valued clients. Visit Swift Scientific website here.
Quick-Neuron™ Precursor differentiated cell cultures continue to proliferate and express a variety of NPC markers, such as nestin (NES), vimentin (VIM), Hes Family BHLH Transcription Factor 5 (HES5), SRY-Box Transcription Factor 1 (SOX1), and SRY-Box Transcription Factor 2 (SOX2). Differentiation achieved in just 6 days Proprietary transcription factor-based stem cell differentiation No genetic footprint Viable […]
Our Quick-Neuron™ Sensory differentiated cell cultures display typical neurite outgrowth and express a variety of neuronal markers, such as tubulin beta 3 class III (TUBB3) and variety of sensory neuron markers such as peripherin (PRPH), islet-1 (ISL1), and brain-specific homeobox/POU domain protein 3A (BRN3A/POU4F1). • Differentiation achieved in just 10 days • Proprietary transcription factor-based […]
Our Quick-Neuron™ Precursor – Human iPSC-derived Neural Precursor Cells (NPCs) proliferate and express a variety of NPC markers, such as neuroectodermal stem cell marker, Nestin (NES) and Vimentin (VIM). • Available from multiple healthy and patient iPSC lines • Proprietary transcription factor-based stem cell differentiation • No genetic footprint • Viable long-term • Suitable for […]